Request a Proposal

Mobile and digital solutions

We pioneered the use of mobile and digital technology to deliver “in-the-moment” market research to the global pharmaceutical industry. We can support you with digital research solutions during the global COVID-19 pandemic.

We employ the full range of digital methodologies to collect rich, global insights both qualitatively and quantitatively.

Online depth interviews
Using tools such as Zoom and InterVu to conduct in-depth interviews virtually.

Online surveys
Research conducted online with all respondent types, involving a mix of closed and open questions.

Online/ virtual focus groups
Synchronous (real-time) online discussions over a set time period (e.g. 2 hours) led by a moderator.  

Mobile surveys
Research conducted via mobile, usually via a survey app, which can include audio responses, video and photo uploads. Surveys can also be run using social tools such as WhatsApp and WeChat.

Bulletin boards
Asynchronous research (conducted in own time) via a moderator-led discussion, lasting between 3-6 days. 

Facial analysis
Analysis of emotional reactions to visual stimuli using facial recognition software, used primarily in communications research. 

MROCs (moderated online research community)
Asynchronous research (conducted in own time) over a longer period to collect longitudinal insights from patients or physicians. Respondents can participate in different tasks and share experiences. 

Social media listening
Analysis of social media activity to a particular disease or healthcare topic, evaluating language, sentiment and content. 

Virtual backroom brainstorm
Making use of online chat tools and private rooms so that clients can dicuss insights in real time.

UX and usability testing
Can be conducted qualitatively or quantitatively, this research is used to understand user behaviours, needs and motivations for engaging with digital assets through observation techniques and task analysis.


Proprietary methodologies

We have also developed our own techniques using digital tools, to deliver additional depths of insight:

Rx Rationale - uses mobile app technology to capture the reasons for product selection at the point of prescription, when the physician has just seen a patient and has made the decision about the best course of treatment.

Rx Potential uses mobile app technology to evaluate your pre-launch product profile with physicians in both a theoretical and real-life clinical setting to get a truer picture of physician decisions. It can be used to build an initial physician segmentation.

Conference Live uses mobile technology to deliver real-time insights from physicians at conference and evaluates the impact of conference marketing before, during and after the event. It can also be used to evaluate virtual conferences.  

Emotional analysis used in conjunction with traditional research methods, AI technology is used to evaluate emotional responses to stimuli and provides an additional layer of insight.

iComply - uses mobile technology to measure compliance in a less obtrusive way. Diaries tend to skew people’s behaviour. iComply uses the intercept method to access insights from a new angle, in a way that respondents aren’t expecting.

iDetail -
our rigorous approach to testing materials delivered on a tablet or iPad ensures your detail aids are optimised for sales effectiveness.

COVID-19 »

Request more information on mobile and digital solutions

By completing this form you agree to receive email communications, including free resources, webinars and event invitations. You can update your preferences or opt out at any time.

John Branston


John is a Director in the European client service team. He has 17 years experience in healthcare market research, conducting both qualitative and quantitative projects. In 2000, he started to explore and develop the use of the internet as a research tool. John won the Jack Hayhurst Award for best paper at the EphMRA Conference 2012 in Paris for his presentation on mobile research and is pioneering new research approaches using this methodology.

John Branston